These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 27768763)

  • 41. DNA Methylation, Mechanisms of
    Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells.
    Avitzour M; Mor-Shaked H; Yanovsky-Dagan S; Aharoni S; Altarescu G; Renbaum P; Eldar-Geva T; Schonberger O; Levy-Lahad E; Epsztejn-Litman S; Eiges R
    Stem Cell Reports; 2014 Nov; 3(5):699-706. PubMed ID: 25418717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hotspot for deletions in the CGG repeat region of FMR1 in fragile X patients.
    de Graaff E; Rouillard P; Willems PJ; Smits AP; Rousseau F; Oostra BA
    Hum Mol Genet; 1995 Jan; 4(1):45-9. PubMed ID: 7711733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FMR1 Reactivating Treatments in Fragile X iPSC-Derived Neural Progenitors In Vitro and In Vivo.
    Vershkov D; Fainstein N; Suissa S; Golan-Lev T; Ben-Hur T; Benvenisty N
    Cell Rep; 2019 Mar; 26(10):2531-2539.e4. PubMed ID: 30840878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monitoring for Epigenetic Modifications at the FMR1 Locus.
    Epsztejn-Litman S; Eiges R
    Methods Mol Biol; 2019; 1942():29-48. PubMed ID: 30900173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene.
    Hansen RS; Gartler SM; Scott CR; Chen SH; Laird CD
    Hum Mol Genet; 1992 Nov; 1(8):571-8. PubMed ID: 1301165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
    Gerhardt J
    Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contraction of fully expanded FMR1 alleles to the normal range: predisposing haplotype or rare events?
    Maia N; Loureiro JR; Oliveira B; Marques I; Santos R; Jorge P; Martins S
    J Hum Genet; 2017 Feb; 62(2):269-275. PubMed ID: 27784894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel fragile X syndrome mutation reveals a conserved role for the carboxy-terminus in FMRP localization and function.
    Okray Z; de Esch CE; Van Esch H; Devriendt K; Claeys A; Yan J; Verbeeck J; Froyen G; Willemsen R; de Vrij FM; Hassan BA
    EMBO Mol Med; 2015 Apr; 7(4):423-37. PubMed ID: 25693964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions.
    Kim K; Hessl D; Randol JL; Espinal GM; Schneider A; Protic D; Aydin EY; Hagerman RJ; Hagerman PJ
    PLoS One; 2019; 14(12):e0226811. PubMed ID: 31891607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An origin of DNA replication in the promoter region of the human fragile X mental retardation (FMR1) gene.
    Gray SJ; Gerhardt J; Doerfler W; Small LE; Fanning E
    Mol Cell Biol; 2007 Jan; 27(2):426-37. PubMed ID: 17101793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The feasibility and utility of hair follicle sampling to measure FMRP and FMR1 mRNA in children with or without fragile X syndrome: a pilot study.
    Jalnapurkar I; Frazier JA; Roth M; Cochran DM; Foley A; Merk T; Venuti L; Ronco L; Raines S; Cadavid D
    J Neurodev Disord; 2022 Dec; 14(1):57. PubMed ID: 36494616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.
    Pietrobono R; Pomponi MG; Tabolacci E; Oostra B; Chiurazzi P; Neri G
    Nucleic Acids Res; 2002 Jul; 30(14):3278-85. PubMed ID: 12136110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells.
    Li M; Zhao H; Ananiev GE; Musser MT; Ness KH; Maglaque DL; Saha K; Bhattacharyya A; Zhao X
    Stem Cells; 2017 Jan; 35(1):158-169. PubMed ID: 27422057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-wide screening for genes involved in the epigenetic basis of fragile X syndrome.
    Vershkov D; Yilmaz A; Yanuka O; Nielsen AL; Benvenisty N
    Stem Cell Reports; 2022 May; 17(5):1048-1058. PubMed ID: 35427485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio.
    Godler DE; Tassone F; Loesch DZ; Taylor AK; Gehling F; Hagerman RJ; Burgess T; Ganesamoorthy D; Hennerich D; Gordon L; Evans A; Choo KH; Slater HR
    Hum Mol Genet; 2010 Apr; 19(8):1618-32. PubMed ID: 20118148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The fragile X phenotype in a mosaic male with a deletion showing expression of the FMR1 protein in 28% of the cells.
    de Graaff E; de Vries BB; Willemsen R; van Hemel JO; Mohkamsing S; Oostra BA; van den Ouweland AM
    Am J Med Genet; 1996 Aug; 64(2):302-8. PubMed ID: 8844070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.